Genome Medical Acquires GeneMatters

Mapmygenome Completes Acquisition of dnaPower

October 21, 2026

Healthcare Services

Mapmygenome completed its acquisition of Vancouver-based dnaPower, adding consumer DNA testing and capabilities in microbiome health, pharmacogenetics, longevity, and multi-omics to its precision-health platform. The combination expands Mapmygenome’s North American presence and integrates dnaPower with Mapmygenome’s laboratory infrastructure and analytics capabilities.

Genomate Health Acquires Oncompass Medicine

January 14, 2026

Healthcare Services

Genomate Health, a Cambridge-based precision medicine company, has acquired Hungarian personalized oncology firm Oncompass Medicine to expand its precision-oncology offerings and establish a stronger presence in Europe. The acquisition brings Oncompass's oncology decision‑support capabilities and customer relationships into Genomate's computational precision‑medicine platform.

InformedDNA Acquires gWell Health

September 21, 2023

Healthcare Services

InformedDNA has acquired gWell Health, a digital health and genomics-driven wellness platform, and appointed gWell founder Surya Singh, MD as InformedDNA's CEO. The deal will combine InformedDNA's clinical genomics expertise with gWell's technology to expand precision-health offerings across prevention, musculoskeletal care, oncology, drug metabolism and maternity care; financial terms were not disclosed.

Dotmatics Acquires SoftGenetics to Expand Genetic Analysis Capabilities

June 12, 2023

Software

Dotmatics has acquired SoftGenetics, a bioinformatics software company that provides genetic analysis tools for research, clinical, and forensic applications. The acquisition expands Dotmatics' R&D scientific software portfolio by adding SoftGenetics' suite of sequencing and genotyping products while allowing SoftGenetics to operate as a standalone business within Dotmatics.

AMP Agency Acquires Genome

May 24, 2022

Marketing & Advertising

AMP Agency, a full-service digital marketing agency and part of Advantage Solutions, has acquired Genome, an award-winning digital innovation and product development company. The acquisition strengthens AMP Agency's technology and product capabilities and supports its strategy to scale technology-enabled innovation and expand internationally; Genome's leadership will join AMP in senior technology roles.

Tesis Biosciences Acquires Genome Explorations

February 16, 2022

Biotechnology

Tesis Biosciences has acquired Genome Explorations to accelerate its clinical research and product development efforts in targeted genetic sequencing and precision medicine. The acquisition brings Genome Explorations’ genomic profiling and molecular diagnostics capabilities and clinical research staff into Tesis’ integrated platform to speed development of proprietary therapeutics and diagnostic products.